CCR2 and idiopathic pulmonary fibrosis: Brody et al. found that CCR2+(chemokine C-C motif receptor 2) macrophages accumulated significantly around fibrous tissue while studying lung tissue from patients with IPF, and that the antifibrotic drug pirfenidone could effectively reduce the accumulation of these macrophages (Brody et al., 2021).